Does the media favor WOSG or DOCS?

In the previous week, Watches of Switzerland Group and Watches of Switzerland Group both had 1 articles in the media. Dr. Martens' average media sentiment score of 0.53 beat Watches of Switzerland Group's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Watches of Switzerland Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Dr. Martens 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, DOCS or COA?

Coats Group has higher revenue and earnings than Dr. Martens. Coats Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dr. Martens £764.90M 0.83 £68.97M £2.40 27.75 Coats Group £1.60B 0.96 £75.12M £5.39 14.93

Is DOCS or COA more profitable?

Coats Group has a net margin of 6.60% compared to Dr. Martens' net margin of 3.11%. Coats Group's return on equity of 14.43% beat Dr. Martens' return on equity. Company Net Margins Return on Equity Return on Assets Dr. Martens 3.11% 6.89% 8.12% Coats Group 6.60% 14.43% 8.48%

Does the media refer more to DOCS or COA?

In the previous week, Dr. Martens and Dr. Martens both had 1 articles in the media. Dr. Martens' average media sentiment score of 0.53 beat Coats Group's score of 0.18 indicating that Dr. Martens is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dr. Martens 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Coats Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend DOCS or MUL?

Dr. Martens currently has a consensus price target of GBX 105, indicating a potential upside of 57.66%. Given Dr. Martens' stronger consensus rating and higher possible upside, equities analysts plainly believe Dr. Martens is more favorable than Mulberry Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Martens 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Mulberry Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, DOCS or MUL?

Dr. Martens has higher revenue and earnings than Mulberry Group. Mulberry Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dr. Martens £764.90M 0.83 £68.97M £2.40 27.75 Mulberry Group £125.47M 1.30 -£39.32M -£13.00 N/A

Do analysts prefer DOCS or PTD?

Dr. Martens currently has a consensus target price of GBX 105, suggesting a potential upside of 57.66%. Given Dr. Martens' stronger consensus rating and higher probable upside, research analysts clearly believe Dr. Martens is more favorable than Pittards. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Martens 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Pittards 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, DOCS or PTD?

Dr. Martens has higher revenue and earnings than Pittards. Pittards is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dr. Martens £764.90M 0.83 £68.97M £2.40 27.75 Pittards £20.37M 0.00 N/A £0.03 N/A

Is DOCS or PTD more profitable?

Dr. Martens has a net margin of 3.11% compared to Pittards' net margin of 1.97%. Dr. Martens' return on equity of 6.89% beat Pittards' return on equity. Company Net Margins Return on Equity Return on Assets Dr. Martens 3.11% 6.89% 8.12% Pittards 1.97% 3.08% 2.32%

Do analysts rate NBU or DOCS?

Dr. Martens has a consensus target price of GBX 105, suggesting a potential upside of 57.66%. Given Dr. Martens' stronger consensus rating and higher possible upside, analysts clearly believe Dr. Martens is more favorable than Naibu Global International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Naibu Global International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Dr. Martens 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67

Which has stronger valuation & earnings, NBU or DOCS?

Dr. Martens has higher revenue and earnings than Naibu Global International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Naibu Global International N/A N/A N/A N/A N/A Dr. Martens £764.90M 0.83 £68.97M £2.40 27.75

Dr. Martens (DOCS) Competitors

GBX 66.60 -0.50 (-0.75%)

As of 10/2/2026 12:41 PM Eastern

Compare

DOCS vs. WOSG, COA, MUL, PTD, and NBU

Should you buy Dr. Martens stock or one of its competitors? Dr. Martens's main competitors and comparable companies include Watches of Switzerland Group (WOSG), Coats Group (COA), Mulberry Group (MUL), Pittards (PTD), and Naibu Global International (NBU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "textiles, apparel & luxury goods" industry.

How does Dr. Martens compare to Watches of Switzerland Group?

Watches of Switzerland Group (LON:WOSG) and Dr. Martens (LON:DOCS) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

Watches of Switzerland Group has a net margin of 5.42% compared to Dr. Martens' net margin of 3.11%. Watches of Switzerland Group's return on equity of 16.31% beat Dr. Martens' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Watches of Switzerland Group	5.42%	16.31%	7.41%
Dr. Martens	3.11%	6.89%	8.12%

53.9% of Watches of Switzerland Group shares are held by institutional investors. Comparatively, 32.2% of Dr. Martens shares are held by institutional investors. 4.4% of Watches of Switzerland Group shares are held by company insiders. Comparatively, 2.9% of Dr. Martens shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Watches of Switzerland Group and Watches of Switzerland Group both had 1 articles in the media. Dr. Martens' average media sentiment score of 0.53 beat Watches of Switzerland Group's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Watches of Switzerland Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dr. Martens	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Watches of Switzerland Group has a beta of 1.863, suggesting that its share price is 86% more volatile than the broader market. Comparatively, Dr. Martens has a beta of 0.262, suggesting that its share price is 74% less volatile than the broader market.

Watches of Switzerland Group presently has a consensus price target of GBX 696.67, suggesting a potential upside of 3.59%. Dr. Martens has a consensus price target of GBX 105, suggesting a potential upside of 57.66%. Given Dr. Martens' stronger consensus rating and higher probable upside, analysts clearly believe Dr. Martens is more favorable than Watches of Switzerland Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Watches of Switzerland Group	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Dr. Martens has lower revenue, but higher earnings than Watches of Switzerland Group. Watches of Switzerland Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Watches of Switzerland Group	£1.83B	0.85	£60.02M	£42.60	15.79
Dr. Martens	£764.90M	0.83	£68.97M	£2.40	27.75

Summary

Watches of Switzerland Group beats Dr. Martens on 8 of the 15 factors compared between the two stocks.

How does Dr. Martens compare to Coats Group?

Dr. Martens (LON:DOCS) and Coats Group (LON:COA) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Dr. Martens currently has a consensus target price of GBX 105, suggesting a potential upside of 57.66%. Coats Group has a consensus target price of GBX 121.20, suggesting a potential upside of 50.65%. Given Dr. Martens' higher possible upside, equities analysts plainly believe Dr. Martens is more favorable than Coats Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Coats Group	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

32.2% of Dr. Martens shares are owned by institutional investors. Comparatively, 64.2% of Coats Group shares are owned by institutional investors. 2.9% of Dr. Martens shares are owned by insiders. Comparatively, 3.2% of Coats Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Dr. Martens has a beta of 0.262, meaning that its stock price is 74% less volatile than the broader market. Comparatively, Coats Group has a beta of 1.258, meaning that its stock price is 26% more volatile than the broader market.

Dr. Martens pays an annual dividend of GBX 2.55 per share and has a dividend yield of 3.8%. Coats Group pays an annual dividend of GBX 3.28 per share and has a dividend yield of 4.1%. Dr. Martens pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Coats Group pays out 60.9% of its earnings in the form of a dividend. Coats Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Coats Group has a net margin of 6.60% compared to Dr. Martens' net margin of 3.11%. Coats Group's return on equity of 14.43% beat Dr. Martens' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	3.11%	6.89%	8.12%
Coats Group	6.60%	14.43%	8.48%

In the previous week, Dr. Martens and Dr. Martens both had 1 articles in the media. Dr. Martens' average media sentiment score of 0.53 beat Coats Group's score of 0.18 indicating that Dr. Martens is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dr. Martens	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Coats Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Coats Group has higher revenue and earnings than Dr. Martens. Coats Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£764.90M	0.83	£68.97M	£2.40	27.75
Coats Group	£1.60B	0.96	£75.12M	£5.39	14.93

Summary

Coats Group beats Dr. Martens on 14 of the 17 factors compared between the two stocks.

How does Dr. Martens compare to Mulberry Group?

Dr. Martens (LON:DOCS) and Mulberry Group (LON:MUL) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

Dr. Martens currently has a consensus price target of GBX 105, indicating a potential upside of 57.66%. Given Dr. Martens' stronger consensus rating and higher possible upside, equities analysts plainly believe Dr. Martens is more favorable than Mulberry Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Mulberry Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

32.2% of Dr. Martens shares are owned by institutional investors. Comparatively, 0.5% of Mulberry Group shares are owned by institutional investors. 2.9% of Dr. Martens shares are owned by insiders. Comparatively, 1.4% of Mulberry Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Dr. Martens had 1 more articles in the media than Mulberry Group. MarketBeat recorded 1 mentions for Dr. Martens and 0 mentions for Mulberry Group. Dr. Martens' average media sentiment score of 0.53 beat Mulberry Group's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the media.

Company	Overall Sentiment
Dr. Martens	Positive
Mulberry Group	Neutral

Dr. Martens has a net margin of 3.11% compared to Mulberry Group's net margin of -6.72%. Mulberry Group's return on equity of 78.71% beat Dr. Martens' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	3.11%	6.89%	8.12%
Mulberry Group	-6.72%	78.71%	-8.70%

Dr. Martens has higher revenue and earnings than Mulberry Group. Mulberry Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£764.90M	0.83	£68.97M	£2.40	27.75
Mulberry Group	£125.47M	1.30	-£39.32M	-£13.00	N/A

Dr. Martens has a beta of 0.262, meaning that its share price is 74% less volatile than the broader market. Comparatively, Mulberry Group has a beta of 0.685, meaning that its share price is 32% less volatile than the broader market.

Summary

Dr. Martens beats Mulberry Group on 13 of the 16 factors compared between the two stocks.

How does Dr. Martens compare to Pittards?

Dr. Martens (LON:DOCS) and Pittards (LON:PTD) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

Dr. Martens has a net margin of 3.11% compared to Pittards' net margin of 1.97%. Dr. Martens' return on equity of 6.89% beat Pittards' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	3.11%	6.89%	8.12%
Pittards	1.97%	3.08%	2.32%

Dr. Martens pays an annual dividend of GBX 2.55 per share and has a dividend yield of 3.8%. Pittards pays an annual dividend of GBX 1 per share. Dr. Martens pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Pittards pays out 3,333.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens is clearly the better dividend stock, given its higher yield and lower payout ratio.

Dr. Martens has higher revenue and earnings than Pittards. Pittards is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£764.90M	0.83	£68.97M	£2.40	27.75
Pittards	£20.37M	0.00	N/A	£0.03	N/A

Dr. Martens has a beta of 0.262, meaning that its stock price is 74% less volatile than the broader market. Comparatively, Pittards has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

32.2% of Dr. Martens shares are held by institutional investors. Comparatively, 30.0% of Pittards shares are held by institutional investors. 2.9% of Dr. Martens shares are held by company insiders. Comparatively, 68.6% of Pittards shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Dr. Martens currently has a consensus target price of GBX 105, suggesting a potential upside of 57.66%. Given Dr. Martens' stronger consensus rating and higher probable upside, research analysts clearly believe Dr. Martens is more favorable than Pittards.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Pittards	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Dr. Martens had 1 more articles in the media than Pittards. MarketBeat recorded 1 mentions for Dr. Martens and 0 mentions for Pittards. Dr. Martens' average media sentiment score of 0.53 beat Pittards' score of 0.00 indicating that Dr. Martens is being referred to more favorably in the media.

Company	Overall Sentiment
Dr. Martens	Positive
Pittards	Neutral

Summary

Dr. Martens beats Pittards on 13 of the 16 factors compared between the two stocks.

How does Dr. Martens compare to Naibu Global International?

Naibu Global International (LON:NBU) and Dr. Martens (LON:DOCS) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

32.2% of Dr. Martens shares are owned by institutional investors. 2.9% of Dr. Martens shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Dr. Martens had 1 more articles in the media than Naibu Global International. MarketBeat recorded 1 mentions for Dr. Martens and 0 mentions for Naibu Global International. Dr. Martens' average media sentiment score of 0.53 beat Naibu Global International's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the news media.

Company	Overall Sentiment
Naibu Global International	Neutral
Dr. Martens	Positive

Dr. Martens has a consensus target price of GBX 105, suggesting a potential upside of 57.66%. Given Dr. Martens' stronger consensus rating and higher possible upside, analysts clearly believe Dr. Martens is more favorable than Naibu Global International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Naibu Global International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Dr. Martens has a net margin of 3.11% compared to Naibu Global International's net margin of 0.00%. Dr. Martens' return on equity of 6.89% beat Naibu Global International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Naibu Global International	N/A	N/A	N/A
Dr. Martens	3.11%	6.89%	8.12%

Dr. Martens has higher revenue and earnings than Naibu Global International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Naibu Global International	N/A	N/A	N/A	N/A	N/A
Dr. Martens	£764.90M	0.83	£68.97M	£2.40	27.75

Summary

Dr. Martens beats Naibu Global International on 11 of the 11 factors compared between the two stocks.

Get Dr. Martens News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOCS vs. The Competition

Export

Metric	Dr. Martens	Textiles, Apparel & Luxury Goods Industry	Consumer Discretionary Sector	LON Exchange
Market Cap	£637.47M	£9.78B	£12.24B	£2.81B
Dividend Yield	3.70%	2.71%	71.69%	6.18%
P/E Ratio	27.75	22.18	44.24	366.16
Price / Sales	0.83	9.13	92.22	89,425.30
Price / Cash	14.29	187.93	28.21	27.89
Price / Book	1.76	3.64	3.95	6.83
Net Income	£68.97M	£462.82M	£446.16M	£5.89B
7 Day Performance	-1.77%	-0.37%	-0.88%	-0.73%
1 Month Performance	-6.31%	-2.45%	-4.46%	16.59%
1 Year Performance	-28.66%	3.06%	-7.88%	23.09%

Dr. Martens Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOCS Dr. Martens	3.346 of 5 stars	GBX 66.60 -0.7%	GBX 105 +57.7%	-29.6%	£637.47M	£764.90M	27.75	890	Positive News
WOSG Watches of Switzerland Group	1.2065 of 5 stars	GBX 689 +1.5%	GBX 696.67 +1.1%	+77.1%	£1.59B	£1.83B	16.17	2,942	Gap Down
COA Coats Group	4.2645 of 5 stars	GBX 80.05 -0.7%	GBX 121.20 +51.4%	-2.6%	£1.53B	£1.60B	14.85	19,000	News Coverage Gap Down High Trading Volume
MUL Mulberry Group	N/A	GBX 260.40 -5.7%	N/A	+132.0%	£182.70M	£125.47M	N/A	1,300
PTD Pittards	N/A	N/A	N/A	N/A	£772K	£20.37M	179.17	1,095

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:DOCS) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dr. Martens (DOCS) Competitors

DOCS vs. WOSG, COA, MUL, PTD, and NBU

How does Dr. Martens compare to Watches of Switzerland Group?

Summary

How does Dr. Martens compare to Coats Group?

Summary

How does Dr. Martens compare to Mulberry Group?

Summary

How does Dr. Martens compare to Pittards?

Summary

How does Dr. Martens compare to Naibu Global International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOCS vs. The Competition

Dr. Martens Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dr. Martens (DOCS) Competitors

DOCS vs. WOSG, COA, MUL, PTD, and NBU

How does Dr. Martens compare to Watches of Switzerland Group?

Is WOSG or DOCS more profitable?

Do institutionals and insiders believe in WOSG or DOCS?

Does the media favor WOSG or DOCS?

Which has more volatility and risk, WOSG or DOCS?

Do analysts rate WOSG or DOCS?

Which has higher valuation and earnings, WOSG or DOCS?

Summary

How does Dr. Martens compare to Coats Group?

Do analysts prefer DOCS or COA?

Do insiders & institutionals believe in DOCS or COA?

Which has more risk & volatility, DOCS or COA?

Is DOCS or COA a better dividend stock?

Is DOCS or COA more profitable?

Does the media refer more to DOCS or COA?

Which has stronger valuation and earnings, DOCS or COA?

Summary

How does Dr. Martens compare to Mulberry Group?

Do analysts recommend DOCS or MUL?

Do institutionals & insiders believe in DOCS or MUL?

Does the media refer more to DOCS or MUL?

Is DOCS or MUL more profitable?

Which has higher valuation and earnings, DOCS or MUL?

Which has more volatility & risk, DOCS or MUL?

Summary

How does Dr. Martens compare to Pittards?

Is DOCS or PTD more profitable?

Is DOCS or PTD a better dividend stock?

Which has preferable valuation and earnings, DOCS or PTD?

Which has more volatility & risk, DOCS or PTD?

Do institutionals and insiders believe in DOCS or PTD?

Do analysts prefer DOCS or PTD?

Does the media prefer DOCS or PTD?

Summary

How does Dr. Martens compare to Naibu Global International?

Do insiders and institutionals hold more shares of NBU or DOCS?

Does the media prefer NBU or DOCS?

Do analysts rate NBU or DOCS?

Is NBU or DOCS more profitable?

Which has stronger valuation & earnings, NBU or DOCS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOCS vs. The Competition

Dr. Martens Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools